|
EP1712226A3
(en)
*
|
1996-04-05 |
2007-03-21 |
The General Hospital Corporation |
Treatment of a Hemoglobinopathy
|
|
US6315995B1
(en)
*
|
1996-09-27 |
2001-11-13 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating an ischemic disorder and improving stroke outcome
|
|
US8128963B2
(en)
|
1996-09-27 |
2012-03-06 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating ischemic disorders using carbon monoxide
|
|
WO1999049803A1
(en)
*
|
1998-04-01 |
1999-10-07 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
|
|
US7678390B2
(en)
|
1999-04-01 |
2010-03-16 |
Yale University |
Carbon monoxide as a biomarker and therapeutic agent
|
|
FR2816212A1
(fr)
*
|
2000-11-03 |
2002-05-10 |
Air Liquide Sante Int |
Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
|
|
US20030198639A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Frenette Paul S. |
Methods of treating sickle cell disease
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
EP1404811B1
(en)
*
|
2001-06-21 |
2008-11-12 |
Beth Israel Deaconess Medical Center, Inc. |
Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
|
|
US6472390B1
(en)
*
|
2001-11-13 |
2002-10-29 |
Duke University |
Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
|
|
US7011854B2
(en)
|
2002-02-04 |
2006-03-14 |
Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
|
|
SG148850A1
(en)
*
|
2002-02-13 |
2009-01-29 |
Beth Israel Hospital |
Methods of treating vascular disease
|
|
EA200401365A1
(ru)
|
2002-04-15 |
2005-04-28 |
Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн |
Способы лечения илеуса
|
|
WO2003088981A1
(en)
*
|
2002-04-15 |
2003-10-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Methods of treating necrotizing enterocolitis
|
|
WO2003088748A1
(en)
|
2002-04-15 |
2003-10-30 |
Beth Israel Deaconess Medical Center |
Use of heme oxygenase-1 and products of heme degradation
|
|
EA200401525A1
(ru)
*
|
2002-05-17 |
2006-06-30 |
Йейл Юниверсити |
Способы лечения гепатита (варианты )
|
|
DE10230165A1
(de)
|
2002-07-04 |
2004-01-15 |
Ino Therapeutics Gmbh |
Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
|
|
EP1558084A4
(en)
*
|
2002-11-07 |
2008-04-30 |
Univ Pittsburgh |
TREATMENT OF HEMORRHAGIC SHOCK
|
|
EP1684579A1
(en)
|
2003-10-22 |
2006-08-02 |
Fred Hutchinson Cancer Research Center |
Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
|
|
EP1552840A1
(en)
*
|
2004-01-07 |
2005-07-13 |
Aga Ab |
Use of a xenon/carbon monoxide mixture for the protection of cells
|
|
SI2264043T1
(en)
|
2005-09-02 |
2018-01-31 |
Glycomimetics, Inc. |
HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
|
|
WO2009126556A1
(en)
|
2008-04-08 |
2009-10-15 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
EP2356224A4
(en)
*
|
2008-11-10 |
2012-12-26 |
Sinai School Medicine |
METHOD OF INHIBITING WEB TREATMENT IN CONNECTION WITH INFLAMMATION THROUGH NEUTROPHILACTIVITY INHIBITION
|
|
CN101732348B
(zh)
*
|
2008-11-11 |
2015-01-14 |
威世药业（如皋）有限公司 |
牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
|
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
US9163044B2
(en)
|
2011-04-19 |
2015-10-20 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
|
PT2794626T
(pt)
|
2011-12-22 |
2018-01-12 |
Glycomimetics Inc |
Compostos de antagonistas de e-selectina
|
|
EP2842966B1
(en)
|
2012-04-27 |
2018-08-15 |
Nihon University |
Therapeutic agent for epithelial and endothelial injury
|
|
CA2891514C
(en)
|
2012-12-07 |
2020-08-25 |
Glycomimetics, Inc. |
Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
|
|
ES2754549T3
(es)
|
2014-12-03 |
2020-04-20 |
Glycomimetics Inc |
Inhibidores heterobifuncionales de E-selectinas y receptores de quimioquinas CXCR4
|
|
WO2017151708A1
(en)
|
2016-03-02 |
2017-09-08 |
Glycomimetics, Inc. |
Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
|
|
EP3497131B1
(en)
|
2016-08-08 |
2022-03-09 |
GlycoMimetics, Inc. |
Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
|
|
US11072625B2
(en)
|
2016-10-07 |
2021-07-27 |
Glycomimetics, Inc. |
Highly potent multimeric e-selectin antagonists
|
|
CA3054605A1
(en)
|
2017-03-15 |
2018-09-20 |
Glycomimetics, Inc. |
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
|
|
WO2019108750A1
(en)
|
2017-11-30 |
2019-06-06 |
Glycomimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
|
CN111566117A
(zh)
|
2017-12-29 |
2020-08-21 |
糖模拟物有限公司 |
E-选择蛋白和半乳凝素-3的异双功能抑制剂
|
|
WO2019173229A1
(en)
|
2018-03-05 |
2019-09-12 |
Glycomimetics, Inc. |
Methods for treating acute myeloid leukemia and related conditions
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
US20230263832A1
(en)
*
|
2020-07-10 |
2023-08-24 |
Children's Medical Center Corporation |
Targeted drug delivery to sites of intravascular occlusion
|